Document ID: chunk:federal_register_of_legislation:F2024C00209:reg:9:p2
Version: federal_register_of_legislation:F2024C00209
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 9172–11789

onset of soft tissue sarcoma, where the first exposure to arsenic occurred at least five years before the clinical onset of soft tissue sarcoma;
Note: being exposed to arsenic and angiosarcoma are defined in the Schedule 1 - Dictionary.
(9)          for uterine sarcoma only, undergoing treatment with tamoxifen for a period of at least 2 months before the clinical onset of soft tissue sarcoma;
(10)      being treated with an immunosuppressive drug resulting in substantial suppression of immune responses:
(a)          to prevent transplant rejection;
(b)          to treat malignant cancer; or
(c)          to treat systemic autoimmune disease;
         before the clinical onset of soft tissue sarcoma;
(11)      being infected with human immunodeficiency virus before the clinical onset of soft tissue sarcoma;
(12)      for uterine sarcoma only, having diabetes mellitus for at least 5 years before the clinical onset of soft tissue sarcoma;
(13)      for angiosarcoma only, having persistent chronic lymphoedema of the affected region for at least 6 months before the clinical onset of soft tissue sarcoma;
Note: angiosarcoma is defined in the Schedule 1 - Dictionary.
(14)      having cutaneous scarring for at least 3 years before the clinical onset of soft tissue sarcoma at that site;
(15)      for cutaneous atypical fibroxanthoma only, having chronic solar skin damage involving the area of skin affected by the cutaneous atypical fibroxanthoma at the time of the clinical onset of soft tissue sarcoma;
(16)      being obese for a period of at least 5 years within the 20 years before the clinical onset of soft tissue sarcoma;
Note: being obese is defined in the Schedule 1 - Dictionary.
(17)      for angiosarcoma only, having an arteriovenous fistula at the site of the angiosarcoma, at least 5 years before the clinical onset of soft tissue sarcoma;
Note: angiosarcoma is defined in the Schedule 1 - Dictionary.
(18)      for angiosarcoma only, having a vascular graft at the site of the angiosarcoma, at least 5 years before the clinical onset of soft tissue sarcoma;
Note: angiosarcoma is defined in the Schedule 1 - Dictionary.
(19)      for endometrial stromal sarcoma only, having endometriosis before the clinical onset of soft tissue sarcoma, where the soft tissue sarcoma has arisen in close proximity to the endometriosis;
(20)      having chronic osteomyelitis at the affected site at least 15 years before the clinical onset of soft tissue sarcoma;
(21)      inability to obtain appropriate clinical management for soft tissue sarcoma before the clinical worsening of soft tissue sarcoma.